These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11991536)

  • 1. Immunoassay screening of lysergic acid diethylamide (LSD) and its confirmation by HPLC and fluorescence detection following LSD ImmunElute extraction.
    Grobosch T; Lemm-Ahlers U
    J Anal Toxicol; 2002 Apr; 26(3):181-6. PubMed ID: 11991536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
    Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
    J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the diagnostic performance of the Boehringer Mannheim CEDIA LSD assay.
    Verstraete AG; Steyaert S
    J Anal Toxicol; 1998; 22(7):601-4. PubMed ID: 9847012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-positive LSD testing in urine samples from intensive care patients.
    Röhrich J; Zörntlein S; Lotz J; Becker J; Kern T; Rittner C
    J Anal Toxicol; 1998 Sep; 22(5):393-5. PubMed ID: 9737335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of LSD in human body fluids and hair samples applying ImmunElute columns.
    Röhrich J; Zörntlein S; Becker J
    Forensic Sci Int; 2000 Jan; 107(1-3):181-90. PubMed ID: 10689571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and interpretation of lysergic acid diethylamide results by immunoassay screening of urine in various testing groups.
    Wu AH; Feng YJ; Pajor A; Gornet TG; Wong SS; Forte E; Brown J
    J Anal Toxicol; 1997; 21(3):181-4. PubMed ID: 9171199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study.
    Schwettmann L; Külpmann WR; Vidal C
    Clin Chem Lab Med; 2006; 44(4):479-87. PubMed ID: 16599844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LSD screening in urine performed by CEDIA® LSD assay: positive interference with sertraline.
    Citterio-Quentin A; Seidel E; Ramuz L; Parant F; Moulsma M
    J Anal Toxicol; 2012 May; 36(4):289-90. PubMed ID: 22511703
    [No Abstract]   [Full Text] [Related]  

  • 9. The analysis of lysergide (LSD): the development of novel enzyme immunoassay and immunoaffinity extraction procedures together with an HPLC-MS confirmation procedure.
    Webb KS; Baker PB; Cassells NP; Francis JM; Johnston DE; Lancaster SL; Minty PS; Reed GD; White SA
    J Forensic Sci; 1996 Nov; 41(6):938-46. PubMed ID: 8914284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation of LSD intoxication by analysis of serum and urine.
    McCarron MM; Walberg CB; Baselt RC
    J Anal Toxicol; 1990; 14(3):165-7. PubMed ID: 2374406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of lysergic acid diethylamide in human urine: elimination, screening and analytical confirmation].
    Vu-Duc T; Vernay A; Calanca A
    Schweiz Med Wochenschr; 1991 Dec; 121(50):1887-90. PubMed ID: 1759150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development and application of a gas chromatography-mass spectrometric (GC-MS) assay to determine the presence of 2-oxo-3-hydroxy-LSD in urine.
    Burnley BT; George S
    J Anal Toxicol; 2003; 27(4):249-52. PubMed ID: 12820748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-positive LSD drug screening induced by a mucolytic medication.
    Lotz J; Hafner G; Röhrich J; Zörntlein S; Kern T; Prellwitz W
    Clin Chem; 1998 Jul; 44(7):1580-1. PubMed ID: 9665451
    [No Abstract]   [Full Text] [Related]  

  • 14. Interference with testing for lysergic acid diethylamide.
    Ritter D; Cortese CM; Edwards LC; Barr JL; Chung HD; Long C
    Clin Chem; 1997 Apr; 43(4):635-7. PubMed ID: 9105265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a nonisotopic immunoassay for the detection of LSD in human urine.
    Cassells NP; Craston DH; Hand CW; Baldwin D
    J Anal Toxicol; 1996 Oct; 20(6):409-15. PubMed ID: 8889677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability study of LSD under various storage conditions.
    Li Z; McNally AJ; Wang H; Salamone SJ
    J Anal Toxicol; 1998 Oct; 22(6):520-5. PubMed ID: 9788528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-mS analysis of human urine specimens for 2-oxo-3-hydroxy LSD: method validation for potential interferants and stability study of 2-oxo-3-hydroxy LSD under various storage conditions.
    Klette KL; Horn CK; Stout PR; Anderson CJ
    J Anal Toxicol; 2002; 26(4):193-200. PubMed ID: 12054358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD.
    Poch GK; Klette KL; Hallare DA; Manglicmot MG; Czarny RJ; McWhorter LK; Anderson CJ
    J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):23-33. PubMed ID: 10202954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD).
    Mardal M; Johansen SS; Thomsen R; Linnet K
    Forensic Sci Int; 2017 Sep; 278():e14-e18. PubMed ID: 28803722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoassay analysis of lysergic acid diethylamide.
    Cody JT; Valtier S
    J Anal Toxicol; 1997 Oct; 21(6):459-64. PubMed ID: 9323526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.